MediKarma Validates Agentic AI in Clinical Study With Dallas Endocrinology

February 22, 2026
MediKarma reported that its Agentic AI platform achieved a 50% A1C improvement rate in a 120-day study with Dallas Endocrinology, leading to a 20,000-unit deployment with Family Health Choice.

San Francisco-based MediKarma reported successful results from a 120-day clinical intervention study with Dallas Endocrinology, validating its Agentic AI platform’s clinical efficacy, announced in a press release. The study showed that 50% of participants reduced or maintained healthy A1C levels, while the platform achieved a 35% monthly active user rate and 100% participant engagement.

The trial deployed “Diabetes Jill,” an autonomous agent functioning as a 24/7 extension of the care team. MediKarma’s system connects to healthcare providers, retrieves patients’ clinical histories, and builds personalized profiles within minutes, enabling proactive patient guidance without manual data handling.

The company stated that these outcomes supported a 20,000-unit deployment with Family Health Choice, which selected MediKarma’s platform to automate patient engagement and improve care gap closure. MediKarma plans to enhance the system further using behavioral science models to increase engagement and clinical performance.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

02/22
Trust AI Launches Isaac PracticeOS, an AI-Powered Dental Management Platform
02/22
Tennr Appoints Dr. William H. Morris as Chief Medical Officer
02/22
Admanager Launches Licensed Content Marketplace for Healthcare AI
02/13
Iambic and Takeda Partner on AI-Driven Small Molecule Drug Discovery
02/13
Robots & Pencils Releases AI-Focused Series on Healthcare Supply Chain Safety

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more

You May Also Like